在人类心肌病症中分离的线粒体生物发生反应
Preeti Ahuja1, Jonathan Wanagat, Zhihua Wang
1Department of Anesthesiology, Division of Molecular Medicine, David Geffen School of Medicine at UCLA, BH-569 CHS, BOX 957115, Los Angeles, CA 90095, USA. Pahuja@mednet.ucla.edu
Circulation
|April 17, 2013
概括
心力衰竭中的线粒体功能障碍与DNA损伤和缺失有关,特别是在扩张性心肌病症中. 这表明有缺陷的补偿反应加剧了氧化应激.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 遗传学 是一个遗传学.
背景情况:
- 线粒体在心力衰竭 (HF) 发病过程中起着至关重要的作用.
- 线粒体功能障碍会损害能量生产,促进细胞死亡,加剧左心室衰竭.
- 在HF中线粒体功能障碍的确切机制仍然不清楚.
研究的目的:
- 在人类心力衰竭中调查线粒体形态,生物发生和基因组完整性.
- 为了比较心脏不衰竭,缺血性心肌病 (ICM) 和扩张性心肌病 (DCM) 的线粒体特征.
主要方法:
- 来自不衰竭,ICM和DCM心脏的左心室组织的分析.
- 评估线粒体形态,数量,体积密度和mtDNA拷贝数.
- 评估mtDNA编码的基因表达,mtDNA修复和抗氧化剂基因表达.
- 量化mtDNA删除突变的量化.
主要成果:
- 在ICM和DCM中观察到线粒体功能障碍.
- 与ICM相比,DCM心脏的线粒体较小,数量更多,体积密度增加,mtDNA复制数增加.
- 在DCM中增加mtDNA编码基因的表达,但在失败的心脏中减少mtDNA修复和抗氧化基因表达.
- 在DCM心脏中发现mtDNA删除突变的显著增加.
结论:
- 在DCM中,线粒体功能障碍与mtDNA损伤和缺失有关.
- 这可能是由于突变性压力和线粒体生物发生的补偿性增加造成的.
- 这种反应似乎是不适应的,增加了氧化损伤,并强调了对DCM线粒体功能障碍的新治疗策略的需要.
相关概念视频
Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Mitochondrial Membranes
11.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.7K
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy
957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957


